There were a few long reads that I’ll be re-reading over the weekend, including: New blood (at Fortune, by Roger Parloff @rparloff) This article profiles the blood diagnostics company, Theranos, and the founder, Elizabeth Holmes. While you will find the founder description interesting, I found myself drawn to the questions of business model, trade secrets and regulation.
Events – WI Biotech
- Reading about how drug prices set, thought of recent WSJ "The High-Speed Trading Behind Your Amazon Purchase" news.morningstar.com/all/dow-jones/… 1 day ago
- I am SO excited to try this new Twitter feature! 👍👍👍 https://t.co/tbSBHACYx5 1 day ago
- RT @bijans: Fantastic article by @DrSidMukherjee on deep learning, AI, neural nets and their potential impact on medicine. "Knowing why"...… 3 days ago
- Biotech Key Clusters vs Rest reminds my '12 post "Human Capital in Biotech: Recycle Reuse Reduce" scientre.co/human-capital-… Still feels right 1 week ago